US medtech group issues guiding principles for device DTC ads
This article was originally published in RAJ Devices
US medtech industry association AdvaMed has for the first time issued a set of voluntary guiding principles for the direct-to-consumer advertising of medical devices1,2. The 13 guiding principles, which are designed to ensure that DTC advertising for devices provides the most accurate and meaningful information for patients, “set a high bar” for the responsible use of DTC advertising by device companies, says AdvaMed.
You may also be interested in...
While inspection interviews can be stressful for drug firms, a Dutch pharmacovigilance inspector reassures companies that any responses made during the process cannot undo any good work they have already done. And they can also correct any wrong answers later on.
The Saudi Food & Drug Authority looks at the number of individual case safety reports (ICSRs) submitted by a company, among other risk-based factors, when drawing up its list for routine pharmacovigilance inspections.
Based on its experience of reviewing tools used by companies for additional risk minimization, the European Medicines Agency is planning to update its guidance on this topic with more information on how these tools can be better employed.